Fig. 1. Patient flow through the study. * According to the randomization schedule, this patient should have received rocuronium-sugammadex, but in error received succinylcholine. The patient was included in the succinylcholinetreated population, but in the intent-totreat population for rocuronium-sugammadex. † According to the randomization schedule, these two patients should have received succinylcholine, but in error received rocuronium-sugammadex. They were included in the rocuronium-sugammadex–treated population, but in the intent-totreat population for succinylcholine.